| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |